Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia
- 15 August 2003
- Vol. 22 (1) , 96-103
- https://doi.org/10.1016/s0264-410x(03)00521-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Pneumococcal PneumoniaPublished by Springer Nature ,2002
- The burden of pneumococcal disease among adults in developed and developing countries: what is and is not knownVaccine, 1999
- Magnitude, Duration, Quality, and Function of Pneumococcal Vaccine Responses in Elderly AdultsThe Journal of Infectious Diseases, 1998
- Antibody Response to Pneumococcal Capsular Polysaccharide Vaccine in the ElderlyThe Journal of Infectious Diseases, 1996
- Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysisJAMA, 1996
- Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumoniaArchives of internal medicine (1960), 1994
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineNew England Journal of Medicine, 1991
- Pneumococcal Polysaccharide Vaccine in Young Adults and Older Bronchitics: Determination of IgG Responses by ELISA and the Effect of Adsorption of Serum with Non-Type-Specific Cell Wall PolysaccharideThe Journal of Infectious Diseases, 1990
- Immune Response of Elderly Adults to Pneumococcus: Variation by Age, Sex, and Functional ImpairmentJournal of Gerontology, 1987
- Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within GroupsThe Journal of Infectious Diseases, 1983